South Africa is revising its rules governing the customisation of medicines, including sought-after GLP-1 treatments for diabetes and weight ​loss, health regulators said, warning pharmacies not to act as small-scale ‌manufacturers.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in